Reaction
Hyperaemia reporting signals
As of the last recalculation, Hyperaemia appears in 1,951 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is THEOPHYLLINE (PRR 12.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Theophylline | 13 | 12.1 | 12.2 |
| Theophylline Anhydrous | 14 | 12.1 | 12.1 |
| Granisetron Hydrochloride | 11 | 11.3 | 11.3 |
| Granisetron | 11 | 11.2 | 11.3 |
| Brimonidine Tartrate | 18 | 10.9 | 10.9 |
| Pegaspargase | 12 | 10.5 | 10.5 |
| Iohexol | 8 | 10.3 | 10.3 |
| Travoprost | 8 | 9.9 | 9.9 |
| Meropenem | 27 | 9.1 | 9.1 |
| Atropine | 7 | 9.0 | 9.0 |
| Pertuzumab | 21 | 8.3 | 8.3 |
| Ketoprofen | 10 | 8.2 | 8.2 |
| Bimatoprost | 21 | 7.8 | 7.9 |
| Amphetamine | 6 | 7.8 | 7.8 |
| Ado-Trastuzumab Emtansine | 6 | 7.6 | 7.6 |
| Paclitaxel (Aibumin-Bound) | 57 | 7.6 | 7.6 |
| Amikacin | 11 | 6.9 | 6.9 |
| Paclitaxel | 61 | 6.8 | 6.8 |
| Ritonavir 100 Mg | 9 | 6.5 | 6.5 |
| Sevoflurane | 5 | 6.4 | 6.4 |
| Rocuronium Bromide | 7 | 6.4 | 6.4 |
| Mepolizumab | 28 | 6.1 | 6.1 |
| Oxaliplatin | 40 | 5.9 | 5.9 |
| Vemurafenib | 6 | 5.3 | 5.3 |
| Obinutuzumab | 8 | 5.2 | 5.2 |
| Trametinib | 11 | 4.9 | 4.9 |
| Cenegermin-Bkbj | 5 | 4.4 | 4.4 |
| Polatuzumab Vedotin | 4 | 4.4 | 4.4 |
| Fentanyl Citrate | 7 | 4.2 | 4.2 |
| Cetuximab | 12 | 4.1 | 4.1 |
| Panitumumab | 6 | 4.1 | 4.1 |
| Dabrafenib | 8 | 4.1 | 4.1 |
| Lifitegrast | 6 | 3.9 | 3.9 |
| Alteplase | 5 | 3.6 | 3.6 |
| Peginterferon Beta-1A | 4 | 3.3 | 3.3 |